Skip to content
10-Q

Quarterly Report

Astera Labs, Inc. ALAB

0001736297-25-000031

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 164.92M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $86.43M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $79.55M
Current Liabilities Q1 2025 · Mar 31, 2025 $77.28M
Current Liabilities Q1 2025 · Dec 31, 2024 $86.54M
Total Liabilities Q1 2025 · Mar 31, 2025 $80.13M
Total Liabilities Q1 2025 · Dec 31, 2024 $89.71M
Current Assets Q1 2025 · Mar 31, 2025 $1.08B
Current Assets Q1 2025 · Dec 31, 2024 $1.01B
Total Assets Q1 2025 · Mar 31, 2025 $1.12B
Total Assets Q1 2025 · Dec 31, 2024 $1.05B
Shares Diluted Q1 2025 · Mar 31, 2024 52.53M sh
Capex Q1 2025 · Mar 31, 2024 $3.42M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $3.65M
Stockholders Equity Q1 2025 · Mar 31, 2024 $808.78M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$97.7M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.77
Eps Basic Q1 2025 · Mar 31, 2024 −$1.77
Sga Expense Q1 2025 · Mar 31, 2024 $24.42M
Rd Expense Q1 2025 · Mar 31, 2024 $53.56M
Net Income Q1 2025 · Mar 31, 2024 −$93M
Operating Income Q1 2025 · Mar 31, 2024 −$82.97M
Gross Profit Q1 2025 · Mar 31, 2024 $50.52M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $14.74M
Revenue Q1 2025 · Mar 31, 2024 $65.26M